Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|October 8, 2004
The effect of clarithromycin, fluconazole, and rifabutin on sulfamethoxazole hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283)Helen R Winter, Carol B Trapnell, John T Slattery, et al.
Clinical Pharmacology and Therapeutics|September 17, 2004
Diminishing the risk of nonrelapse mortality in hematopoietic stem cell transplantation: Prediction of exposure to the cyclophosphamide metabolite carboxyethylphosphoramide mustardRuolun Qiu, Amy Yao, Paolo Vicini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Real-time dose adjustment of cyclophosphamide in a preparative regimen for hematopoietic cell transplant: a Bayesian pharmacokinetic approachDavid H Salinger, Jeannine S McCune, Aaron G Ren, et al.
Blood|October 31, 2002
Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantationGeorge B McDonald, John T Slattery, Michelle E Bouvier, et al.
Clinical Pharmacology and Therapeutics|September 13, 2005
Metabolism-based cyclophosphamide dosing for hematopoietic cell transplantGeorge B McDonald, Jeannine S McCune, Ami Batchelder, et al.
Blood|September 8, 2005
Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantationLuisa Giaccone, Jeannine S McCune, Michael B Maris, et al.
Clinical Pharmacology and Therapeutics|June 18, 2003
Transiently altered acetaminophen metabolism after liver transplantationJeong M Park, Yvonne S Lin, Justina C Calamia, et al.
Blood|April 5, 2003
Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cellsMartin Bornhauser, Barry Storer, John T Slattery, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2005
A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantationRichard A Nash, Laura Johnston, Pablo Parker, et al.
Blood|August 1, 2002
Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndromeH Joachim Deeg, Barry Storer, John T Slattery, et al.
Pageof 3